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 Cruzain is an essential cysteine protease in Trypanosoma cruzi (T. cruzi), the causative 
agent of Chagas’ disease.1 Cruzain is an ideal target for development of potential trypanocidal 
drugs because of its critical role in the survival of T. cruzi in infected human hosts. 
Crystallographic analysis of cruzain treated with the covalent inactivator K11777, a 
peptidomimetic compound with an electrophilic vinyl sulfone substituent, undergoes the 
formation of a stable C-S bond between cruzain and the vinyl group of the inactivator. We seek 
to develop new cruzain inactivators in which the vinyl-sulfone group is replaced by isoelectronic 
vinyl--heterocycle groups which may provide reversible covalent inactivation of cruzain, which 
would be less subject to selectivity and toxicity problems that plague irreversible inactivators. 
This report examines the potential of 2-vinyl heterocycles as inhibitors for cruzain by NMR 
analysis of the thia-Michael addition to the vinyl bond using β-mercaptoethanol (BME), 
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4-VP  4-VinylPyridine  
2-VP  2-VinylPyridine  
BME  β-mercaptoethanol  
MEA  Cysteamine 
GSH  L-glutathione 





My research goal is to synthesize and  explore the suitability of novel vinyl-heterocyclic 
compounds as reversible Michael acceptors to be used in the development of new inhibitors of 
cysteine proteases of therapeutic interest. The vinyl heterocycle compounds to be synthesized in 
which electron-withdrawing substituents are found on the heterocycle ring, and which are 
isoelectronic with normal Michael acceptors, and determine their utility in thia-Michael addition 
by thiols and thiolates, specifically mercaptoethanol, L-glutathione and cysteamine, using NMR 
spectroscopic analysis.  
Introduction. 
The triatomine bugs defecates on human host skin while it feeds on blood meal from its 
human host. The protozoan parasite Trypanosoma cruzi is found in the feces of the bug, 
therefore the infection occurs when feces are rubbed into the mucous membrane (e.g. eyes) or 
the bite wound.2 T. cruzi enters host cells near the wound site in its trypanomastigote, or 
bloodstream, form. Once in the cell the protozoan parasite transforms into amastigotes, the 
immobile form of the pathogen. 
After, the amastigotes divide, they transform into the mobile pathogen, the 
trypanomastigote form, which then bursts out of the cell and enters the bloodstream. Thus, the 
new trypomastigotes can infect other cells and repeat this lifecycle3. During the acute phase of 
disease, the infected human host either is asymptomatic or manifests a mild illness such as 
swelling at the site of the infection. When Chagas’s disease advances into the chronic phase it 
can become deadly, resulting in heart failure, gastrointestinal problems, and increased risk of 
5 
stroke. A total of approximately 12 million people in Latin America and 300,000 in the United 
States are infected with Chagas’s disease4. Current treatments face toxicity problems: 
chemotherapy with K11777 (clinical trials in humans are about to begin), nifurtimox, or 
benznidazole are undesirable because of the severe side effects. The drug K11777 targets the 
essential cysteine protease cruzain by forming a stable covalent bond with the vinyl sulfone 
substituent.5 However, irreversible inactivators have limitations such as selectivity for target 
cysteine proteases and toxicity.6 
In addition, the consensus mechanism for cysteine proteases involves nucleophilic attack 
by the cysteine thiol on the scissile peptide bond. As shown in Figure 1, in the enzyme’s active 
site the thiol is deprotonated by the nitrogen in the histidine residue (Schneck et al. 2008; Zhai 
and Meek, manuscript in preparation). Once deprotonated, the thiolate undergoes nucleophilic 
attack to form an enzyme thioester with concomitant release of the amine product. Thus, the 
histidine residue is restored to its original deprotonated form and an intermediate with the 
cysteine thiol link to the thioester is formed. In the de-acylation half-reaction water, de-
protonated by the thioester, hydrolyzes the thioester bond to form the carboxylate product, 
restoring the free enzyme.7 
 
Figure 1. General chemical mechanism of the cysteine proteases.7 
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Thus, we synthesized 2-vinyl heterocycles with different electron-withdrawing and 
donating groups on the heterocycles in hopes of increasing the reactivity with the active site of 
cysteine of cruzain. We will use proton NMR analysis to determine if reversible covalent bonds 




All air and moisture sensitive reactions were carried out in oven-dried glassware under a 
nitrogen atmosphere with anhydrous solvents. All commercial reagents were obtained from 
commercial available sources and used without further purification. Proton NMR spectra of all 
reaction mixtures were performed on a 400 Hz Bruker AVANCE III HD NMR spectrometer. 
Synthesis of Boc-Phe-CO-N(OCH3)CH3 (2). To a solution of t-Boc-L-phenylalanine (5.03 
g, 18.8 mmol) in anhydrous DCM (100 mL), triethylamine (8 mL, 56 mmol, 3 eq),was added 1-
propanephosphonic acid cyclic anhydride (18 mL, 28.2 mmol, 1.5 eq). The reaction mixture was 
placed in an ice bath and N,O-dimethylhydroxylamine hydrochloride was added  (2.76 g, 28.2 
mmol, 1.5 eq). The resulting yellow murky reaction mixture was stirred for 30 minutes. The 
reaction mixture was extracted with dichloromethane (DCM;100 mL, 3X),  and then washed 
with water and brine. The combined organic layer was dried with Na2SO4, and concentrated 
under reduced pressure to afford a yellow oil (5.55 g, 95%). 1H NMR (400 MHz, CDCl3): δ 
7.19-7.14 (m, 5H), 4.92 (t, J=6.6 Hz, 1H), 3.66 (s, 1H), 3.44 (d, J=11.5 Hz, 1H), 2.71 (s, 2H), 
1.32 (s, 9H). MS (ES) m/z 209.46 (M – H), Rt= 4.83 min. 
Synthesis of Boc-Phe-COH (3). Boc-Phe-CO-N(OCH3)CH3 was dissolved in anhydrous 
THF (55 mL),  and placed in an ice bath containing NaCl. To this clear solution, LiAlH4 (11.25 
mL, 22.3 mmol, 1.25 eq) was added dropwise, and the resultant reaction mixture was stirred for 
1 h. The reaction mixture was quenched at 0℃ by adding 5% HCl in H2O and a white precipitate 
formed. The resulting mixture was neutralized with sodium bicarbonate and concentrated under 
vacuum.  The resulting white solid was diluted with H2O, extracted with ethyl acetate (3 x 200 
mL), and the organic layer was washed with brine. The combined organic layer was dried with 
8 
Na2SO4, filtered and concentrated to afford a light yellow oil (4.46 g, 100%). 
 1H NMR (400 
MHz, CDCl3): δ 9.72 (s, 1H), 7.35-7.25 (m, 5H), 4.11 (t, J=7.7Hz, 1H), 3.12 (d, J=8 Hz, 2H), 
1.48 (s, 1H). 
Synthesis of Boc-Phe-2-Vinyl-Pyridine (5). To a solution of triphenylphosphonium  2-
methylpyridine (4) (1.96 g, 4.57 mmol) in THF (50 mL) under nitrogen atmosphere was placed 
in an ethanol-dry ice bath (-70℃) added dropwise lithium bis(trimethylsilyl)amide (10 mL, 6.4 
mmol, 2.2 eq). After stirring for 15 min at -70℃ Boc-Phe-H in 5 mL of THF was added 
dropwise and stirred at -70℃ for 1h. The reaction was quenched by adding glacial acetic acid 
(0.1 mL), and immediately sodium bicarbonate(30 mL).  The reaction mixture was transferred 
into a separatory funnel. The water layer was extracted with ethyl acetate (2 x 200 mL), washed 
with brine and dried the combined organic layers on sodium sulfate. Filtered off the drying agent 
and filtrate was concentrated to get the crude product, which was purified by column 
chromatography (5%-20% ethyl acetate/hexane) to afford a clear oil (0.19 g, 18.8%). 1H NMR 
(400 MHz, CDCl3): δ 8.5 (d, J=4.3 Hz, 2H), 7.62 (t, J=6.41 Hz, 1H), 7.32-7.28 (m, 3H), 7.25-
7.22 (m, 5H), 6.75-6.69 (m, 1H), 6.57 (d, J=15.8 Hz, 1H),4.34 (m, 1H), 3.04 (m, 2H), 1.32 (s, 
3H). MS (ES) m/z 325.3 (M – H), Rt= 3.7 min. 
Synthesis of methyl methanesulfonate (6). Into a three-neck round bottom flask was added 
sodium bicarbonate (6 g) and water (10 mL) to make a supersaturated solution, which was placed 
under an ice bath (9 ℃). To this solution dichloromethane (20 mL), triethylamine (0.27 mL, 1.94 
mmol, 0.03 eq), methanol (6.3 mL, 155.04 mmol, 2.4 eq), and methanesulfonyl chloride (5 mL, 
64.6 mmol) were added, and the reaction was stirred overnight under an ice bath. The subnatant 
organic layer was decanted and concentrated to afford the product methyl methanesulfonate 
(2.64 g, 37%). 1H NMR (400 MHz, CDCl3): δ 3.87 (s, 3H), 2.97 (s, 1H).8 
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Methylation of Boc-Phe-2-Vinyl-Pyridine (7). Methyl methanesulfonate (50.9 mg, 0.462 
mmol) and Boc-Phe-Vinyl-Pyridine (100 mg, 0.31 mmol) were added into a vial with benzene (4 
mL), sealed and stirred at room temperature for 2 weeks. However, NMR analysis showed that 
the vinyl proton peaks were absent.9 
Methylation of Triphenylphosphonium salt of  2-methylpyridine (8). Into a mixture of ice 
(2.42 g) and sodium carbonate (0.0613 g), the phosphonium 2-methylpyridine  (0.41 g, 0.94 
mmol) was added and dissolved with ethyl acetate. The pH was checked to be basic (pH 8) and 
extracted with ethyl acetate. The combined organic layers were dried with sodium sulfate and 
concentrated. The resulting white precipitate was dissolved in benzene and methyl 
methanesulfonate (0.156 g, 1.4 mmol, 1.5 eq) was added, and the reaction mixture was stirred at 
room temperature for 2 weeks.9 The reaction was unsuccessful. 
Synthesis of 2-(Boc-amino)pyrimidine (9). To a solution (in an ice bath) of 2-
aminopyrimidine (2.02 g, 21 mmol) in dichloromethane (30 mL), di-tert-butyl dicarbonate (6.65 
g, 25.2 mmol, 1.2 eq), DMAP (0.28 g, 2.1 mmol), and triethylamine (4.4 mL, 31.5 mmol) were 
added under nitrogen atmosphere. The resulting yellow murky solution was stirred at room 
temperature for 2h. The reaction mixture was diluted with water, extracted with 
dichloromethane, washed with brine and the combined organic layers were dried with sodium 
sulfate and concentrated to afford an orange oil. The oil was purified by column chromatography 
(10%-25% ethyl acetate/hexane) to afford a clear oil (3.26 g, 78%). 1H NMR (400 MHz, CDCl3): 
δ 8.74 (d, J= 4.8 Hz, 2H), 6.91 (t, J= 4.7 Hz, 1H), 1.43 (s, 3H). 
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Synthesis of 4-vinyl-2-(Boc-amino)pyrimidine (10). To a solution of 2-(t-Boc-
amino)pyrimidine in THF (10 mL)  in a Dry Ice/acetone  bath, vinyl magnesium bromide was 
added dropwise. The resulting yellow solution was stirred for 2h. However, NMR analysis did 
not show new vinyl proton peaks.10 
1-Methyl-2-vinylpyridinium iodide (11). To a solution of 2-vinylpyridine (700 mg, 6.66 
mmol) in methanol (10 mL), methyl iodide (4.5 g, 31 mmol) was added and stirred for 48 h at 
room temperature. The solvent was removed under rotary evaporation and the solid washed three 
times with Et2O. After drying under vacuum a dark green oil (400 mg), was recovered. 
1H NMR 
(400 MHz, D2O) δ 8.68 (d, J= 6.3 Hz, 2 H), 7.79 (d, J= 8.7 Hz, 2 H), 6.82-6.6.75 (dd, J1= 11.2 
Hz, J2= 11.0 Hz, 1H),6.09 (d, J= 17.7 Hz,1 H), 5.54 (d, J=11.4 Hz, 1 H), 3.31 (s, 3 H)
11; MS 
(ES) m/z 120.4 (M – H), Rt= 0.36min. 
1-Methyl-4-vinylpyridinium Iodide (12). To a solution of 4-vinylpyridine (0.68 g, 6.5 
mmol) in methanol (10 mL), methyl iodide (4.56 g, 32.1 mmol) was added and stirred for 48 h at 
room temperature. The solvent was evaporated and the resulting solid washed with Et2O (4 × 20 
mL) and CH3OH (50 mL), dried in a vacuum, and recrystallized with EtOH-Et2O to obtain a 
light yellow solid (1.39 g, 86.9%). 1H NMR (400 MHz, D2O) δ 8.60 (d, J= 6.7 Hz, 2 H), 7.89 (d, 
J= 6.1 Hz, 2 H), 6.95-6.88 (dd, J1= 12.3 Hz, J2= 10.7 Hz,  1H), 6.42 (d, J= 17.7 Hz, 1 H), 5.94 (d, 
J= 10.7 Hz, 1 H), 3.55 (s, 3 H) ; MS (ES) m/z 120.4 (M – H), Rt= 0.47min.12 
Methylation of compound 5 (13). To a solution of compound 5 (96.1 m g, 0.296 mmol) in 
methanol (10 mL), methyl iodide (0.21 g, 1.48 mmol) was added and stirred for 48 h at room 
temperature. The solvent was evaporated and the resulting solid washed with Et2O (4 × 20 mL) 
and CH3OH (50 mL), dried in a vacuum, and recrystallized with EtOH-Et2O to obtain a light 
yellow solid (64.4 mg, 64%). 1H NMR (400 MHz, D2O) δ 8.85 (d, J= 7.1 Hz, 1 H), 8.50 (t, J= 
11 
7.1 Hz,  1 H), 8.23 (d, J= 8.3 Hz,  1H), 7.92 (t, J= 7.1 Hz, 1H), 7.35-7.23 (m, 5H), 6.99-6.94 (m, 
1H), 6.87 (d, J= 16.1 Hz, 1 H), 4.67 (m, 1 H), 4.25 (s, 3 H), 1.44 (s, 9 H); MS (ES) m/z 339.3 (M 
– H), Rt= 0.53min.12 
NMR Analysis of Michael Addition with Thiols.  As an example of the thiolate addition 
studies, L-glutathione was mixed with compound 11 (4.1 mg, 0.034 mmol) dissolved in D2O (0.5 
mL) in a standard 5 mm NMR tube, and the spectrum was recorded (Figure 5 blue spectrum). L-
glutathione (27.4 mg, 0.089 mmol, 3 mol equiv) was then added, and the spectrum was recorded 






The t-Boc phenylalanine derivative containing the 2-vinyl pyridine (compound 5) was the 
first compound in our studies to be synthesized, and it was examined for the thia-Michael 
addition to the vinyl bond by NMR analysis.  Compound 5 was synthesized from Boc-L-
phenylalanine (AK Scientific).  As shown in scheme 1, the carboxylic acid group on the Boc-L-
phenylalanine was converted to a Weinreb amide 2, followed by its reduction to an aldehyde 
3.Then 2-vinyl pyridine (compound 5) was prepared by the Wittig reaction of aldehyde 3 with  
the triphenylphosphonium ylide (4).  
 
Scheme 1. Synthetic plan for making compound 5. 
Once compound 5 was purified it was reacted with a Michael donor, 2-mercaptoethanol 
(BME), in DMSO-d6/ D2O (3:1) at 10:1 eq:eq to compound 5. One drop of NaOD was added to 
13 
the thia-Michael reaction in order to deprotonate BME. The reaction was monitored hourly by 
proton NMR but no addition was detected. Even after 1 week BME did not attack the vinyl bond 
in compound 5.  Thus, having the nitrogen in the 2 position in the pyridine group is not the best 
position for thia-Michael additions. Using the same conditions for the thia-Michael addition 
reaction for compound 5, the vinyl benzene derivative of t-Boc phenylalanine (compound LL-
26; synthesized by a coworker, Linfeng Li, in the Meek lab) was monitored by proton NMR.  
Unsurprisingly, since there is insufficient electron withdrawal in the vinyl-benzene group, in 
comparison to the  vinyl sulfone group in  K11777, whereinthe thiolate  performs  a nucleophilic 
attack on the vinyl bond after being deprotonated by the histidine residue.  
 
Figure 2. Thia-Michael addition reactions for compound 5 and LL-26. In an NMR tube 10 mM 
of compound 5 and 100 mM of BME + 1 drop of NaOD (pH 11) in 0.5 mL of DMSO-d6/D2O 
(3:1).  
Next, compound BC-90 (synthesized by a coworker, Bala Chenna, in the Meek lab) with 
two electron-withdrawing groups (4,6-dichloro) on the pyrimidine group was treated with BME 
14 
using the same conditions as for compound 5. However, when proton NMR was taken the 
sample was too dilute to obtain an interpretable spectrum.  
 
Figure 3. Thia-Michael addition reactions for compound BC-90.  
As a result of having a limited amount of BC-90, 100 microliters of a 200 mM solution of 
BC-90 was added to the NMR tube. NMR analysis was repeated and the vinyl proton peaks from 
the BC-90 compound were observed (although the sample was not very concentrated) around 6 
ppm. Figure 4, shows the NMR spectrum of the thia-Michael addition reaction with BC-90 after 
zero minutes, shows two doublets (the vinyl protons) between 6.5 and 6.0 ppm. The red 
spectrum was recorded after 1 day. After one day the vinyl proton peaks were absent, indicating 
that  thia-Michael addition from BME had occurred. 
15 
 
Thirdly, it was hypothesized that if the nitrogen in the 2-position of the pyridine ring in 
compound 5 was methylated it would stabilize the negative charge arising from thiolate attack on 
the vinyl group. Thus, an attempt to prepare methylated compound 5 was done using methyl 
methanesulfonate dissolved in benzene. However, after two weeks compound 7 was not 





Figure 5. Methylation of compound 5, 11, and 12. 
Furthermore, since the protocol for the methylation that uses methyl methanesulfonate 
takes two weeks, has poor yields, and most importantly was not successful for compound 5, 
another approach was taken9.  Methylation of 4-vinylpyridine and 2-vinylpyridine was 
 
Figure 4. NMR spectrum from 8 ppm to 4 ppm of BC-90. The blue spectrum is of BC-
90 in DMSO-d6.The red spectrum shows the thia-Michael addition after 1 day. 
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completed by reaction with methyl iodide in methanol for 48 hours. Compounds 11 and 12 were 
characterized by mass spectrometry and proton NMR. The solvent was evaporated under 
pressure, however for higher purity, a recrystallization step should be done. In addition, Avonto 
and coworkers published a paper in Angewandte Chemie (ref) in which they developed a 
protocol to identify Michael acceptors, and test their reversibility by doing a dilution in 
deuterated chloroform13. As a result, a similar experiment to what they report was performed, but 
since the methylated compounds and L-glutathione are soluble in water, D2O was used as the 
NMR solvent instead of DMSO-d6. Two solutions were made with 64.4 mM of compounds 11 
and 12 and 180 mM (3 eq) of L-glutathione in 0.5 mL of D2O. After 5h vinyl proton peaks from 
both reactions were still observed, thus the reaction mixtures were left for 1 day and the 
spectrums was the recorded. After 1 day both reactions mixture for compounds 11 and 12 
showed addition of mercaptoethanol to the vinyl group. In Figure 6, the blue spectrum is of the 
pure compounds 11 and the green spectrum is of the pure compound 12. The spectrums for 
compounds 11 and 12 both show a doublet of doublets near 6.80 ppm and two doublets around 
6.10 and 5.50 ppm. The red (11) and purple (12) spectrum show the vinyl proton peaks of 
compounds 11 and 12 were completely eradicated by treatment with mercaptoethanol.  
17 
 
Furthermore, the thia-Michael addition studies was performed with 4-vinylpyridine and 
2-vinylpyridine using 2-mercaptoethanol (BME), cysteamine, and L-glutathione as Michael 
donors. These vinyl-pyridines are models for the incorporation of the vinyl-pyridine substituent 
into peptidomimetics.  As expected 4-vinylpyridine showed addition while 2-vinylpyridine, 
while did not, even after 2 days of incubation. Thus, compound 5 was also N-methylated and 
reacted with L-glutathione using the same conditions for the thia-Michael addition of compounds 
11 and 12.  
 
Figure 6. NMR spectrum from 0-9 ppm of compound 11 and 12.  The blue spectrum is 64.4 mM  
compound 11 in  DMSO-d6.  The  red spectrum contains 64.4 mM  mM compound 11 and 180 
mM  mM mercaptoethanol, and the absence of the vinyl proton peaks between 5.8-6.4 ppm 
indicates full  thia-Michael addition of compound 11 by BME after 1 day. The green spectrum is 
64.4 mM compound 12 in DMSO-d6.  The purple spectrum show the thia-Michael addition of 180 
mM  mM mercaptoethanol to compound 12 after 1 day.  
18 
 
Figure 7. Methylation of compound 5 with methyl iodide in methanol for 48 h. 
Thus, compound 5 was methylated with methyl iodide in methanol for 48 hours, shown 
in Figure 7 . Compound 5 was characterized by mass spectrometry and proton NMR. The 
solvent was evaporated under pressure to afford a yellow powder. After, thia-Michael addition 
was performed by dissolving compound 5 (112 M) in 0.5 mL of DMSO- d6/ d2O (3:1) and 
adding BME (1.12M) and NaOD (10 µL). In approximately 5 minutes, the nucleophilic sulfur in 
BME had added to the vinyl group because the vinyl peaks were absent. Studies done with 
cruzain shows inhibition with compound 13 (with a cbz protecting group instead of Boc), but the 
potency of inhibition is weak (Ki* <10 µM ). 
 
Figure 8. NMR spectra from 5-9 ppm  of 4-vinylpyridine with 2-mercaptoethanol (BME) heated 
at 40 degrees C for 90 minutes. 1) blue NMR spectrum is of pure 192 mM  4-vinylpyridine in 0.5 
19 
mL DMSO-d6. 2) red NMR spectrum is of 192 mM  4-vinylpyridine and 383 mM BME in 0.5 
mL DMSO-d6. 3) Green NMR spectrum is of 192 mM  4-vinylpyridine and 383 mM  L-
glutathione in 0.5 mL D20. 4) Purple NMR spectrum is of 192 mM  4-vinylpyridine and 383 
mM  cysteamine in 0.5 mL DMSO-d6.  Upon adduct formation the pyridine protons’ chemical 
shift move slightly downfield.  
 
Compound 5 was reacted with cysteamine in DMSO-d6 and heated at 40 °C for 3 hours. 
However, cysteamine did not attack the vinyl bond since the vinyl proton peaks remained visible 
at 3 hours and after 5 days. In addition, 4-vinylpyridine was reacted with BME, cysteamine, L-
glutathione, and heated (40 °C) to catalyze the reaction, shown in Figure 8. The spectrum of the 
reaction was recorded at 30 min and 90 min. At 30 minutes vinyl peaks were still visible for all 
three Michael donors. After 90 minutes, the vinyl peaks were absent for the reaction mixtures 
with L-glutathione and BME, but with treatment with cysteamine, traces of the vinyl proton 
peaks remained. Thus, successful thia-Michael addition reactions can be observed in 90 minutes 
if samples are heated, in lieu of a day at ambient temperature to observe addition. L-glutathione 
and BME are better Michael donors than cysteamine, however they each have their limitations. 
L-glutathione is soluble in water, slightly soluble in DMSO, and insoluble in chloroform, thus if 
the vinyl compound is insoluble in water BME is a better Michael donor. BME is miscible in 
water, DMSO, and chloroform. However, in order for BME to be capable of Michael addition, 
about 10 uLs of NaOD must be added.  Without the addition of base, traces of the vinyl proton 
peaks will be visible in NMR after 1 day of incubation. Also, when 3:1equivalents of BME: 
vinyl substrate were used, no addition was observed.Therefore BME must be used in a 10-fold 
equivalent ratio.   
20 
 
Lastly, we attempted to prepare compound 10 from 2-aminopyrimidine. First, the amino 
group was protected using di-tert-butyl dicarbonate to produce compound 9. Next, a Grignard 
reaction was performed using compound 9 and vinyl magnesium bromide in THF. However, the 
reaction was not successful since no vinyl peaks were observed in NMR.  
Scheme 2. Synthetic plan for making compound 10.  
However, mass spectrometry analysis of a 10-microliter sample of the crude compound 
10 indicated that the t-Boc had been removed. Thus, a nominal amount of compound 10 was 






Synthesis of compound 5 was successful however, NMR spectroscopic analysis of its 
thia-Michael reactions with thiols showed that no covalent bond was formed between the thiolate 
and the vinyl β-carbon. Yet, methylation of the nitrogen in 4-vinylpyridine and 2-vinylpyridine 
resulting in analogues that fostered thia-Michael addition. Thus, thia-Michael addition to 
compound 5 was achieved when the pyridine nitrogen is N-methylated. However, the inhibition 
of compound 13 on cruzain was not potent enough. Thus, more heterocycles with electron-
withdrawing groups such as compound BC-90, which shows potential for Michael addition, 
should be explored. Lastly, heating the thia-Michael reaction mixtures will catalyze the addition 
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